相关实验视频

Updated: May 23, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

在瘤免疫和治疗中准蛋白S-palmitoylation方面的进展

Miaomiao Han^1,2, Yuanhao Lv^1,2, Yiyang Chen²

¹Department of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.

Frontiers in oncology

|March 11, 2025

概括

S-palmitoylation是一种蛋白质修饰,影响癌症生长和免疫反应. 针对这一过程显示了增强癌症免疫治疗和克服药物耐药性的前景.

科学领域:

生物化学和分子生物学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

S-palmitoylation是一种可逆的蛋白质修饰,涉及将棕基连接到囊类残留物.
这个过程调节基因表达,细胞信号传递和各种细胞功能.
它与瘤发生和免疫治疗有显著的相关性,影响T细胞激活,细胞因子信号传递和细胞死亡.

研究的目的:

总结关于瘤免疫和治疗的S-palmitoylation研究的最新进展.
检查S-palmitoylation在瘤细胞信号传递中的调节作用.
探索针对S-palmitoylation用于癌症治疗的新型免疫疗法.

主要方法:

关于S-palmitoylation研究近期发展的文献综述.
在癌症中分析S-palmitoylation及其修饰酶的调节功能.
研究针对S-palmitoylation的新型免疫治疗策略.

主要成果:

S-palmitoylation影响瘤细胞的耐药性和免疫逃避.
针对S-palmitoylation的抑制剂在增强瘤免疫治疗疗效方面显示出潜在的潜力.
S-palmitoylation 在调节T细胞激活,细胞因子信号传递,自,细胞和细胞死亡方面发挥着至关重要的作用.

结论:

S-palmitoylation是瘤免疫的关键调节剂,也是潜在的治疗标.
向S-palmitoylation为癌症治疗提供了一种新的策略,特别是与免疫疗法结合使用.
需要进行进一步的研究,以应对开发向疗法的抑制剂特异性和疗效方面的挑战.

关键词:

通过S-palmitoylation进行了S-palmitoylation的治疗.在T细胞,T细胞.药物耐药性耐药性药物耐药性免疫系统的逃脱是免疫逃脱.免疫疗法免疫疗法瘤是一个瘤.

更多相关视频

Detection of Protein S-Acylation using Acyl-Resin Assisted Capture

Detection of Protein S-Acylation using Acyl-Resin Assisted Capture

Published on: April 10, 2020

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-surface Signaling

Cell-surface Signaling

Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...